A Retrospective Review of Antibiotic Management of Infective Endocarditis in a Large Tertiary-Care Teaching Hospital

Anahita Mostaghim^1, , Hoi Yee Annie Lo¹ and Nancy Khardori²

¹School of Medicine, Eastern Virginia Medical School, Norfolk, USA

²Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, USA

Cite this paper:
Anahita Mostaghim, Hoi Yee Annie Lo and Nancy Khardori. A Retrospective Review of Antibiotic Management of Infective Endocarditis in a Large Tertiary-Care Teaching Hospital. American Journal of Infectious Diseases and Microbiology. 2017; 5(3):120-125. doi: 10.12691/ajidm-5-3-5

Abstract

This study aims to analyze duration of intravenous antimicrobial treatment and targeted antimicrobial choices after narrowing from broad-spectrum antibiotics in cases of infective endocarditis (IE) at a large teaching hospital in the U.S. Patients were retrospectively identified from 2007-2015 using appropriate ICD-9 codes. Cases that met definite Modified Duke Criteria were extracted for epidemiologic data, causative organism, antimicrobial regimen choice and length, mortality, and recurrence. Patients treated with at least 6 weeks of intravenous antibiotics had less recurrence than those who received less than 6 weeks (0% vs 9.5%, P = 0.0081) with all cases of recurrence being with Staphylococcal IE. Cefazolin showed a lower in-hospital mortality than nafcillin for methicillin-sensitive staphylococcus aureus (3.3% vs 41.2%, P = 0.0118) although statistically insignificant in coagulase negative staphylococcus IE (16.7% vs 66.7%, P = 0.0992). Cefazolin and vancomycin had similar in-hospital mortality for methicillin-susceptible coagulase-negative staphylococcus (16.7% vs 22.2%). Daptomycin and vancomycin had similar in-hospital mortality in methicillin-resistant S. aureus (0% vs 6.3%). Vancomycin and ampicillin had similar in-hospital mortalities in susceptible enterococcus (16.7% each). Recurrence was tied to use of less than 6 weeks of antibiotics in cases of staphylococcal IE. Cefazolin had lower in-hospital mortality than nafcillin in cases of methicillin-susceptible S. aureus and coagulase-negative staphylococcus. Vancomycin showed similar efficacy to cefazolin, daptomycin, and ampicillin in their respective susceptible species. Randomized control trials need to be held to confirm if antibiotic choice is tied to in-hospital mortality.

Keywords:
infective endocarditis antibiotic cefazolin nafcillin duration mortality recurrence

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Osler, W. (1885). The Gulstonian Lectures, on Malignant Endocarditis. British Medical Journal, 1(1264), 577-579.
[2]	Grinberg, M., & Solimene, M. C. (2011). Historical aspects of infective endocarditis. Revista da Associação Médica Brasileira (English Edition), 57(2), 223-228.
[3]	Cresti, A., Chiavarelli, M., Scalese, M., Nencioni, C., Valentini, S., Guerrini, F., et al. (2017). Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovascular Diagnosis and Therapy, 7(1), 27-35.
[4]	Moreillon, P., & Que, Y. (2004). Infective endocarditis. The Lancet, 363(9403), 139-149.
[5]	Desimone, D. C., Tleyjeh, I. M., Sa, D. D., Anavekar, N. S., Lahr, B. D., Sohail, M. R., et al. (2015). Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. American Heart Journal, 170(4), 830-836.
[6]	Cabell, C. H., Jollis, J. G., Peterson, G. E., Corey, G. R., Anderson, D. J., Sexton, D. J., et al. (2002). Changing Patient Characteristics and the Effect on Mortality in Endocarditis. Archives of Internal Medicine, 162(1), 90.
[7]	Correa d Sa, D. D., Tleyjeh, I. M., Anavekar, N. S., Schultz, J. C., Thomas, J. M., Lahr, B. D., et al. (2010). Epidemiological Trends of Infective Endocarditis: A Population-Based Study in Olmsted County, Minnesota. Mayo Clinic Proceedings, 85(5), 422-426.
[8]	Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., et al. (2015). Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation.
[9]	Martí-Carvajal, A. J., Dayer, M., Conterno, L. O., Garay, A. G., Martí-Amarista, C. E., & Simancas-Racines, D. (2016). A comparison of different antibiotic regimens for the treatment of infective endocarditis. Cochrane Database of Systematic Reviews.
[10]	Rao, S. N., Rhodes, N. J., Lee, B. J., Scheetz, M. H., Hanson, A. P., Segreti, J., Crank, C.W., Wang, S. K. (2015). Treatment Outcomes with Cefazolin versus Oxacillin for Deep-Seated Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections. Antimicrobial Agents and Chemotherapy, 59(9), 5232-5238.
[11]	Topan, A., Carstina, D., Slavcovici, A., Rancea, R., Capalneanu, R., & Lupse, M. (2015). Assesment of the Duke criteria for the diagnosis of infective endocarditis after twenty-years. An analysis of 241 cases. Clujul Medical, 88(3), 321.
[12]	Neragi-Miandoab, S., Skripochnik, E., Michler, R., & D'alessandro, D. (2014). Risk Factors Predicting the Postoperative Outcome in 134 Patients with Active Endocarditis. The Heart Surgery Forum, 17(1), 35.
[13]	Yayla, C., Tekçe, Y, Açar , B., Ünal, S., Ertem, A., Şentürk, B., Aydoğdu, S.(2017). Daptomycin in Left Sided Endocarditis: A Single Center Experience. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology.